Professor Timothy Yang, associate professor and director of the Center for Asian Studies at the University of Georgia, ...
Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
TOKYO -- Japan ... Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the company ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Catalyst Pharmaceuticals, Inc. CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical ...
Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company ... A number of factors, including (i) whether DyDo can successfully commercialize FIRDAPSE in Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback